Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.

TitleMagnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.
Publication TypeJournal Article
Year of Publication2018
AuthorsDeh K, Ponath GD, Molvi Z, Parel G-CT, Gillen KM, Zhang S, Nguyen TD, Spincemaille P, Ma Y, Gupta A, Gauthier SA, Pitt D, Wang Y
JournalJ Magn Reson Imaging
Volume48
Issue5
Pagination1281-1287
Date Published2018 11
ISSN1522-2586
KeywordsAlgorithms, Animals, Autopsy, Biomarkers, Cattle, Humans, Magnetic Resonance Imaging, Multiple Sclerosis, Myelin Basic Protein, Myelin Sheath, Phantoms, Imaging, Trypsin, White Matter
Abstract

BACKGROUND: The pathological processes in the first weeks of multiple sclerosis (MS) lesion formation include myelin digestion that breaks chemical bonds in myelin lipid layers. This can increase lesion magnetic susceptibility, which is a potentially useful biomarker in MS patient management, but not yet investigated.

PURPOSE: To understand and quantify the effects of myelin digestion on quantitative susceptibility mapping (QSM) of MS lesions.

STUDY TYPE: Histological and QSM analyses on in vitro models of myelin breakdown and MS lesion formation in vivo.

POPULATION/SPECIMENS: Acutely demyelinating white matter lesions from MS autopsy tissue were stained with the lipid dye oil red O. Myelin basic protein (MBP), a major membrane protein of myelin, was digested with trypsin. Purified human myelin was denatured with sodium dodecyl sulfate (SDS). QSM was performed on phantoms containing digestion products and untreated controls. In vivo QSM was performed on five MS patients with newly enhancing lesions, and then repeated within 2 weeks.

FIELD STRENGTH/SEQUENCE: 3D T2* -weighted spoiled multiecho gradient echo scans performed at 3T.

ASSESSMENT: Region of interest analyses were performed by a biochemist and a neuroradiologist to determine susceptibility changes on in vitro and in vivo QSM images.

STATISTICAL TESTS: Not applicable.

RESULTS: MBP degradation by trypsin increased the QSM measurement by an average of 112 ± 37 ppb, in excellent agreement with a theoretical estimate of 111 ppb. Degradation of human myelin by SDS increased the QSM measurement by 23 ppb. As MS lesions changed from gadolinium enhancing to nonenhancing over an average of 15.8 ± 3.7 days, their susceptibility increased by an average of 7.5 ± 6.3 ppb.

DATA CONCLUSION: Myelin digestion in the early stages of MS lesion formation contributes to an increase in tissue susceptibility, detectable by QSM, as a lesion evolves from gadolinium enhancing to nonenhancing.

LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2018;47:1281-1287.

DOI10.1002/jmri.25997
Alternate JournalJ Magn Reson Imaging
PubMed ID29517817
PubMed Central IDPMC6129234
Grant ListRG-1602-07671 / / National Multiple Sclerosis Society / International
S10 OD021782 / OD / NIH HHS / United States
R01 NS102267 / NS / NINDS NIH HHS / United States
R01 NS090464 / NH / NIH HHS / United States
R01 NS090464 / NS / NINDS NIH HHS / United States

Weill Cornell Medicine Neurology 525 E. 68th St.
PO Box 117
New York, NY 10065 Phone: (212) 746-6575